nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP1A2—chronic obstructive pulmonary disease	0.36	1	CbGaD
Terbinafine—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0567	0.126	CbGbCtD
Terbinafine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0362	0.0805	CbGbCtD
Terbinafine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0362	0.0805	CbGbCtD
Terbinafine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0327	0.0727	CbGbCtD
Terbinafine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0301	0.0669	CbGbCtD
Terbinafine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0301	0.0669	CbGbCtD
Terbinafine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0284	0.0631	CbGbCtD
Terbinafine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0276	0.0612	CbGbCtD
Terbinafine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0276	0.0612	CbGbCtD
Terbinafine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0246	0.0545	CbGbCtD
Terbinafine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0231	0.0513	CbGbCtD
Terbinafine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0228	0.0507	CbGbCtD
Terbinafine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0156	0.0347	CbGbCtD
Terbinafine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0152	0.0338	CbGbCtD
Terbinafine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0149	0.0331	CbGbCtD
Terbinafine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0133	0.0295	CbGbCtD
Terbinafine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00779	0.0173	CbGbCtD
Terbinafine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00736	0.0163	CbGbCtD
Terbinafine—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000428	0.373	CrCbGaD
Terbinafine—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000367	0.319	CrCbGaD
Terbinafine—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.000354	0.308	CrCbGaD
Terbinafine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00234	CcSEcCtD
Terbinafine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00234	CcSEcCtD
Terbinafine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000292	0.0023	CcSEcCtD
Terbinafine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.0023	CcSEcCtD
Terbinafine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00029	0.00228	CcSEcCtD
Terbinafine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00227	CcSEcCtD
Terbinafine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.00227	CcSEcCtD
Terbinafine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000287	0.00226	CcSEcCtD
Terbinafine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00225	CcSEcCtD
Terbinafine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.00225	CcSEcCtD
Terbinafine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.00223	CcSEcCtD
Terbinafine—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00222	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00222	CcSEcCtD
Terbinafine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00222	CcSEcCtD
Terbinafine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00222	CcSEcCtD
Terbinafine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00221	CcSEcCtD
Terbinafine—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00028	0.0022	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00028	0.0022	CcSEcCtD
Terbinafine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00218	CcSEcCtD
Terbinafine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00218	CcSEcCtD
Terbinafine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.00217	CcSEcCtD
Terbinafine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00217	CcSEcCtD
Terbinafine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00216	CcSEcCtD
Terbinafine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00216	CcSEcCtD
Terbinafine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00214	CcSEcCtD
Terbinafine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.00213	CcSEcCtD
Terbinafine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000267	0.0021	CcSEcCtD
Terbinafine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00209	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00209	CcSEcCtD
Terbinafine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00209	CcSEcCtD
Terbinafine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00209	CcSEcCtD
Terbinafine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00206	CcSEcCtD
Terbinafine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00205	CcSEcCtD
Terbinafine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00204	CcSEcCtD
Terbinafine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00204	CcSEcCtD
Terbinafine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00204	CcSEcCtD
Terbinafine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00203	CcSEcCtD
Terbinafine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00203	CcSEcCtD
Terbinafine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00203	CcSEcCtD
Terbinafine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00203	CcSEcCtD
Terbinafine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00203	CcSEcCtD
Terbinafine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00203	CcSEcCtD
Terbinafine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00203	CcSEcCtD
Terbinafine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00203	CcSEcCtD
Terbinafine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00203	CcSEcCtD
Terbinafine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000258	0.00203	CcSEcCtD
Terbinafine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000258	0.00203	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00202	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00202	CcSEcCtD
Terbinafine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00201	CcSEcCtD
Terbinafine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00201	CcSEcCtD
Terbinafine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00199	CcSEcCtD
Terbinafine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00199	CcSEcCtD
Terbinafine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00199	CcSEcCtD
Terbinafine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00199	CcSEcCtD
Terbinafine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00199	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00198	CcSEcCtD
Terbinafine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.00198	CcSEcCtD
Terbinafine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00197	CcSEcCtD
Terbinafine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00195	CcSEcCtD
Terbinafine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00195	CcSEcCtD
Terbinafine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00194	CcSEcCtD
Terbinafine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00194	CcSEcCtD
Terbinafine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00192	CcSEcCtD
Terbinafine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00192	CcSEcCtD
Terbinafine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00192	CcSEcCtD
Terbinafine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000244	0.00192	CcSEcCtD
Terbinafine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00191	CcSEcCtD
Terbinafine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00191	CcSEcCtD
Terbinafine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00191	CcSEcCtD
Terbinafine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00191	CcSEcCtD
Terbinafine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00191	CcSEcCtD
Terbinafine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.0019	CcSEcCtD
Terbinafine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000241	0.0019	CcSEcCtD
Terbinafine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00189	CcSEcCtD
Terbinafine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00189	CcSEcCtD
Terbinafine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00024	0.00189	CcSEcCtD
Terbinafine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00188	CcSEcCtD
Terbinafine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00187	CcSEcCtD
Terbinafine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00187	CcSEcCtD
Terbinafine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00186	CcSEcCtD
Terbinafine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00184	CcSEcCtD
Terbinafine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00183	CcSEcCtD
Terbinafine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00182	CcSEcCtD
Terbinafine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00181	CcSEcCtD
Terbinafine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00181	CcSEcCtD
Terbinafine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00179	CcSEcCtD
Terbinafine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000227	0.00178	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00178	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00178	CcSEcCtD
Terbinafine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00176	CcSEcCtD
Terbinafine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.00175	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00174	CcSEcCtD
Terbinafine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00172	CcSEcCtD
Terbinafine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00172	CcSEcCtD
Terbinafine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00172	CcSEcCtD
Terbinafine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000218	0.00171	CcSEcCtD
Terbinafine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000216	0.00169	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00168	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00168	CcSEcCtD
Terbinafine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00168	CcSEcCtD
Terbinafine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00168	CcSEcCtD
Terbinafine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00168	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00168	CcSEcCtD
Terbinafine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00167	CcSEcCtD
Terbinafine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00167	CcSEcCtD
Terbinafine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00165	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00165	CcSEcCtD
Terbinafine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00165	CcSEcCtD
Terbinafine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00163	CcSEcCtD
Terbinafine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00163	CcSEcCtD
Terbinafine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00162	CcSEcCtD
Terbinafine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000206	0.00162	CcSEcCtD
Terbinafine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.00161	CcSEcCtD
Terbinafine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00161	CcSEcCtD
Terbinafine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00161	CcSEcCtD
Terbinafine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00161	CcSEcCtD
Terbinafine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.0016	CcSEcCtD
Terbinafine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000203	0.0016	CcSEcCtD
Terbinafine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000203	0.0016	CcSEcCtD
Terbinafine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.0016	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00159	CcSEcCtD
Terbinafine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00159	CcSEcCtD
Terbinafine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00158	CcSEcCtD
Terbinafine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00156	CcSEcCtD
Terbinafine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00155	CcSEcCtD
Terbinafine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00155	CcSEcCtD
Terbinafine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00154	CcSEcCtD
Terbinafine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00154	CcSEcCtD
Terbinafine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00154	CcSEcCtD
Terbinafine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00154	CcSEcCtD
Terbinafine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.00154	CcSEcCtD
Terbinafine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.00152	CcSEcCtD
Terbinafine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.00152	CcSEcCtD
Terbinafine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000194	0.00152	CcSEcCtD
Terbinafine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00152	CcSEcCtD
Terbinafine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00152	CcSEcCtD
Terbinafine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000193	0.00151	CcSEcCtD
Terbinafine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00151	CcSEcCtD
Terbinafine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00151	CcSEcCtD
Terbinafine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00151	CcSEcCtD
Terbinafine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00146	CcSEcCtD
Terbinafine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00146	CcSEcCtD
Terbinafine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00146	CcSEcCtD
Terbinafine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00144	CcSEcCtD
Terbinafine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00144	CcSEcCtD
Terbinafine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000183	0.00144	CcSEcCtD
Terbinafine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00143	CcSEcCtD
Terbinafine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00141	CcSEcCtD
Terbinafine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000178	0.0014	CcSEcCtD
Terbinafine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.0014	CcSEcCtD
Terbinafine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00138	CcSEcCtD
Terbinafine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00138	CcSEcCtD
Terbinafine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00137	CcSEcCtD
Terbinafine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00136	CcSEcCtD
Terbinafine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00135	CcSEcCtD
Terbinafine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00133	CcSEcCtD
Terbinafine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00133	CcSEcCtD
Terbinafine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00132	CcSEcCtD
Terbinafine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00132	CcSEcCtD
Terbinafine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00131	CcSEcCtD
Terbinafine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.0013	CcSEcCtD
Terbinafine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00129	CcSEcCtD
Terbinafine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00129	CcSEcCtD
Terbinafine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00129	CcSEcCtD
Terbinafine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00126	CcSEcCtD
Terbinafine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00126	CcSEcCtD
Terbinafine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00126	CcSEcCtD
Terbinafine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00124	CcSEcCtD
Terbinafine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00124	CcSEcCtD
Terbinafine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00123	CcSEcCtD
Terbinafine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00123	CcSEcCtD
Terbinafine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00123	CcSEcCtD
Terbinafine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00123	CcSEcCtD
Terbinafine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00122	CcSEcCtD
Terbinafine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00122	CcSEcCtD
Terbinafine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00122	CcSEcCtD
Terbinafine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00122	CcSEcCtD
Terbinafine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00122	CcSEcCtD
Terbinafine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00121	CcSEcCtD
Terbinafine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000153	0.0012	CcSEcCtD
Terbinafine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000153	0.0012	CcSEcCtD
Terbinafine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.0012	CcSEcCtD
Terbinafine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000152	0.0012	CcSEcCtD
Terbinafine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00118	CcSEcCtD
Terbinafine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00117	CcSEcCtD
Terbinafine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00117	CcSEcCtD
Terbinafine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00116	CcSEcCtD
Terbinafine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00116	CcSEcCtD
Terbinafine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00116	CcSEcCtD
Terbinafine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00116	CcSEcCtD
Terbinafine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00116	CcSEcCtD
Terbinafine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00115	CcSEcCtD
Terbinafine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00113	CcSEcCtD
Terbinafine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00109	CcSEcCtD
Terbinafine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00109	CcSEcCtD
Terbinafine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00106	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.00106	CcSEcCtD
Terbinafine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00101	CcSEcCtD
Terbinafine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00098	CcSEcCtD
Terbinafine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000976	CcSEcCtD
Terbinafine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000955	CcSEcCtD
Terbinafine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000949	CcSEcCtD
Terbinafine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000947	CcSEcCtD
Terbinafine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000941	CcSEcCtD
Terbinafine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000903	CcSEcCtD
Terbinafine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000886	CcSEcCtD
Terbinafine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000873	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000871	CcSEcCtD
Terbinafine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000869	CcSEcCtD
Terbinafine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000859	CcSEcCtD
Terbinafine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000848	CcSEcCtD
Terbinafine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000845	CcSEcCtD
Terbinafine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000839	CcSEcCtD
Terbinafine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000801	CcSEcCtD
Terbinafine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000801	CcSEcCtD
Terbinafine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000798	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000795	CcSEcCtD
Terbinafine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000791	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	9.9e-05	0.000778	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000768	CcSEcCtD
Terbinafine—Infection—Prednisone—chronic obstructive pulmonary disease	9.7e-05	0.000763	CcSEcCtD
Terbinafine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.000753	CcSEcCtD
Terbinafine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.000746	CcSEcCtD
Terbinafine—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000732	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.000699	CcSEcCtD
Terbinafine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.89e-05	0.000699	CcSEcCtD
Terbinafine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000689	CcSEcCtD
Terbinafine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.000676	CcSEcCtD
Terbinafine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000667	CcSEcCtD
Terbinafine—Rash—Prednisolone—chronic obstructive pulmonary disease	8.47e-05	0.000666	CcSEcCtD
Terbinafine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.47e-05	0.000665	CcSEcCtD
Terbinafine—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.42e-05	0.000662	CcSEcCtD
Terbinafine—Headache—Prednisolone—chronic obstructive pulmonary disease	8.42e-05	0.000662	CcSEcCtD
Terbinafine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.31e-05	0.00135	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.28e-05	0.00135	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.19e-05	0.00133	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—CTGF—chronic obstructive pulmonary disease	8.11e-05	0.00132	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.09e-05	0.00132	CbGpPWpGaD
Terbinafine—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.07e-05	0.00132	CbGpPWpGaD
Terbinafine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000633	CcSEcCtD
Terbinafine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.99e-05	0.000628	CcSEcCtD
Terbinafine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.99e-05	0.0013	CbGpPWpGaD
Terbinafine—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.98e-05	0.000627	CcSEcCtD
Terbinafine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.88e-05	0.00128	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.87e-05	0.00128	CbGpPWpGaD
Terbinafine—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.00061	CcSEcCtD
Terbinafine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000607	CcSEcCtD
Terbinafine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000607	CcSEcCtD
Terbinafine—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.65e-05	0.00125	CbGpPWpGaD
Terbinafine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.64e-05	0.00124	CbGpPWpGaD
Terbinafine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.62e-05	0.00124	CbGpPWpGaD
Terbinafine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.58e-05	0.00123	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.47e-05	0.00122	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	7.32e-05	0.00119	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.32e-05	0.00119	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.31e-05	0.00119	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.26e-05	0.00118	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.24e-05	0.00118	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.22e-05	0.00118	CbGpPWpGaD
Terbinafine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.000566	CcSEcCtD
Terbinafine—CYP11A1—Metabolism—GC—chronic obstructive pulmonary disease	7.12e-05	0.00116	CbGpPWpGaD
Terbinafine—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.000551	CcSEcCtD
Terbinafine—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000543	CcSEcCtD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.88e-05	0.00112	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.8e-05	0.00111	CbGpPWpGaD
Terbinafine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.75e-05	0.0011	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.72e-05	0.0011	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.71e-05	0.00109	CbGpPWpGaD
Terbinafine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000525	CcSEcCtD
Terbinafine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.66e-05	0.00109	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.64e-05	0.00108	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.62e-05	0.00108	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.59e-05	0.00107	CbGpPWpGaD
Terbinafine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.47e-05	0.00105	CbGpPWpGaD
Terbinafine—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.000508	CcSEcCtD
Terbinafine—SQLE—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.23e-05	0.00101	CbGpPWpGaD
Terbinafine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.21e-05	0.000488	CcSEcCtD
Terbinafine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.2e-05	0.00101	CbGpPWpGaD
Terbinafine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.16e-05	0.001	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	6.16e-05	0.001	CbGpPWpGaD
Terbinafine—Rash—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000484	CcSEcCtD
Terbinafine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000484	CcSEcCtD
Terbinafine—SQLE—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.14e-05	0.001	CbGpPWpGaD
Terbinafine—Headache—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000481	CcSEcCtD
Terbinafine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.08e-05	0.000991	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.07e-05	0.000989	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.99e-05	0.000976	CbGpPWpGaD
Terbinafine—Nausea—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.000456	CcSEcCtD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.76e-05	0.000938	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.72e-05	0.000933	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.69e-05	0.000928	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.68e-05	0.000925	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.63e-05	0.000917	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.6e-05	0.000912	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.59e-05	0.00091	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.54e-05	0.000902	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.51e-05	0.000898	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.46e-05	0.00089	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.46e-05	0.00089	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.43e-05	0.000884	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.000859	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.25e-05	0.000856	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.22e-05	0.00085	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.22e-05	0.00085	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.14e-05	0.000838	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.14e-05	0.000837	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.07e-05	0.000825	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5e-05	0.000814	CbGpPWpGaD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5e-05	0.000814	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.000805	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.88e-05	0.000794	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.85e-05	0.000789	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.81e-05	0.000783	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.73e-05	0.00077	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	4.71e-05	0.000768	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.68e-05	0.000763	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.66e-05	0.000759	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.66e-05	0.000758	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.63e-05	0.000754	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.62e-05	0.000752	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.6e-05	0.000749	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.59e-05	0.000748	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.56e-05	0.000742	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.41e-05	0.000719	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.39e-05	0.000716	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.39e-05	0.000715	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.38e-05	0.000714	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.35e-05	0.000709	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.34e-05	0.000708	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.28e-05	0.000697	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.25e-05	0.000693	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.25e-05	0.000692	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.24e-05	0.000691	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.24e-05	0.000691	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.22e-05	0.000688	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.19e-05	0.000682	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.16e-05	0.000678	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.16e-05	0.000678	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.08e-05	0.000665	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.000661	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.05e-05	0.000659	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.02e-05	0.000656	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4e-05	0.000652	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4e-05	0.000652	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.98e-05	0.000648	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.97e-05	0.000646	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.97e-05	0.000646	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.97e-05	0.000646	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.97e-05	0.000646	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.95e-05	0.000643	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.89e-05	0.000634	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.89e-05	0.000633	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.84e-05	0.000626	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.69e-05	0.000601	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—ALB—chronic obstructive pulmonary disease	3.69e-05	0.000601	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.65e-05	0.000595	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.63e-05	0.000591	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.6e-05	0.000587	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.58e-05	0.000584	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.58e-05	0.000583	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.57e-05	0.000582	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.55e-05	0.000578	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—NOS3—chronic obstructive pulmonary disease	3.53e-05	0.000575	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.51e-05	0.000571	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.000569	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.44e-05	0.00056	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.000552	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.27e-05	0.000532	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.24e-05	0.000527	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.23e-05	0.000526	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.05e-05	0.000496	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3e-05	0.000489	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.94e-05	0.000479	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.84e-05	0.000462	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.8e-05	0.000456	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.77e-05	0.000451	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.76e-05	0.00045	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.69e-05	0.000439	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.66e-05	0.000433	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.65e-05	0.000432	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.63e-05	0.000429	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.62e-05	0.000426	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.61e-05	0.000426	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.58e-05	0.00042	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.56e-05	0.000418	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.55e-05	0.000415	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.53e-05	0.000412	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.48e-05	0.000403	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.38e-05	0.000388	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.37e-05	0.000387	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.35e-05	0.000383	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.000382	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.33e-05	0.00038	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.000378	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000376	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.29e-05	0.000373	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.17e-05	0.000353	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.000352	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.14e-05	0.000349	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.14e-05	0.000349	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.000349	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.14e-05	0.000348	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.13e-05	0.000346	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000346	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.1e-05	0.000343	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.09e-05	0.00034	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2e-05	0.000325	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.97e-05	0.000321	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.96e-05	0.000319	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.96e-05	0.000319	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.94e-05	0.000316	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.9e-05	0.000309	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.83e-05	0.000299	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.8e-05	0.000293	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.79e-05	0.000291	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.78e-05	0.00029	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.000287	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.000276	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.66e-05	0.00027	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.64e-05	0.000267	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.6e-05	0.00026	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.000253	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000252	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.53e-05	0.000249	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.5e-05	0.000245	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.48e-05	0.000241	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.41e-05	0.00023	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.000228	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.000225	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.38e-05	0.000225	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.38e-05	0.000224	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.32e-05	0.000215	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.000213	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.29e-05	0.00021	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.28e-05	0.000208	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.000206	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.25e-05	0.000204	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.24e-05	0.000201	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.00019	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.15e-05	0.000188	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.000187	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.14e-05	0.000186	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	0.000185	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.13e-05	0.000184	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000184	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000172	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000171	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.04e-05	0.000169	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.000169	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000167	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000165	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.74e-06	0.000159	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.71e-06	0.000158	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.63e-06	0.000157	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.57e-06	0.000156	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.55e-06	0.000156	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.47e-06	0.000154	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.98e-06	0.000146	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.92e-06	0.000145	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	8.9e-06	0.000145	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.78e-06	0.000143	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.66e-06	0.000141	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.54e-06	0.000139	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.51e-06	0.000139	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.46e-06	0.000138	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.97e-06	0.00013	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.96e-06	0.00013	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.9e-06	0.000129	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.86e-06	0.000128	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.79e-06	0.000127	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.55e-06	0.000123	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.52e-06	0.000122	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.43e-06	0.000121	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.32e-06	0.000119	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.26e-06	0.000118	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.94e-06	0.000113	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.88e-06	0.000112	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.78e-06	0.00011	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.75e-06	0.00011	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.66e-06	0.000108	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.25e-06	0.000102	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.2e-06	0.000101	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.88e-06	9.58e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	5.75e-06	9.36e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	5.5e-06	8.96e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.21e-06	8.49e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.14e-06	8.37e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.13e-06	8.36e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.91e-06	7.99e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.79e-06	7.8e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.72e-06	7.69e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.68e-06	7.62e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.54e-06	7.39e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.51e-06	7.35e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.47e-06	7.29e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4e-06	6.51e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.82e-06	6.23e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.08e-06	5.03e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.95e-06	4.81e-05	CbGpPWpGaD
